SCNN1B and metastatic malignant neoplasm in the lymph nodes: However, the high methylation levels of fragment one in the SCNN1B promoter showed a significant association with advanced tumour stage (P = 0.004) and lymph node metastasis (P = 0.003) in CRC patients.